Matthew Perry’s assistant faces sentencing today in Los Angeles for ketamine death role

Show summary Hide summary

• 🔥 Quick Facts
• The Investigation and Plea Agreement
• Evidence and Testimony in Court Proceedings
• The Broader Federal Case Against Multiple Defendants
• Systemic Issues in Celebrity Healthcare and Addiction Treatment
• What This Sentencing Represents for Legal Accountability
• Will This Case Change How Celebrities Access Medical Care?

Kenneth Iwamasa, the 59-year-old former live-in assistant to Matthew Perry, faces sentencing today in federal court in Los Angeles for his role in the actor’s October 2023 ketamine overdose death. The sentencing marks the final chapter in a 2.5-year federal investigation and prosecution involving five defendants charged in connection with the “Friends” star’s death.

The Investigation and Plea Agreement

Matthew Perry, the beloved “Chandler Bing” actor from the hit sitcom “Friends,” was found unresponsive in his hot tub on October 28, 2023. The Los Angeles County Medical Examiner determined the cause of death was acute ketamine toxicity in a December 2023 autopsy report. Initial circumstances suggested an accidental drowning, but the investigation revealed a complex criminal enterprise supplying the actor with dangerous drugs.

Iwamasa became a key witness for federal prosecutors after initially facing up to 15 years in prison. He was the first of five defendants to reach a guilty plea, providing crucial testimony about how Perry received ketamine injections from medical professionals without legitimate therapeutic justification. The federal prosecution strategy leveraged Iwamasa’s cooperation to build stronger cases against the doctors and drug suppliers who enabled the fatal supply chain.

Evidence and Testimony in Court Proceedings

Court documents revealed that Iwamasa personally administered ketamine injections to Perry on multiple occasions throughout 2023. The toxicology analysis found 3,271 nanograms per milliliter of ketamine in Perry’s blood at death—a concentration within the range used for surgical anesthesia (1,000 to 6,000 nanograms per milliliter). This level of drug exposure would have rendered the actor heavily sedated, contributing to his drowning in the hot tub.

Perry’s family members filed emotional victim impact statements ahead of today’s sentencing. Perry’s mother, Suzanne Morrison, stated her son “paid the price” for trusting his assistant. Perry’s sisters criticized Iwamasa for injecting him with the drug and then leaving him in the hot tub to die. These statements underscored the breach of trust involved—Iwamasa was hired specifically to help Perry maintain sobriety, not facilitate drug use.

The Broader Federal Case Against Multiple Defendants

Federal prosecutors in the Central District of California have now secured convictions and sentences against all five defendants. Dr. Salvador Plasencia, a physician who sold 20 vials of ketamine to Perry for $55,000 in cash between September and October 2023, received 30 months in federal prison in December 2025. Jasveen Sangha, labeled the “Ketamine Queen” by prosecutors, was sentenced to 15 years in federal prison on April 8, 2026, for distributing the drug that led to Perry’s death.

Defendant	Charge	Sentence	Date Sentenced
Dr. Salvador Plasencia	Conspiracy, distribution, operating unlicensed clinic	30 months + 2 years supervised release	December 3, 2025
Jasveen Sangha	Distribution of ketamine causing death	15 years federal prison	April 8, 2026
Dr. Mark Chavez	Conspiracy, fraud, drug distribution	Home confinement	TBA
Erik Fleming	Distribution, drug addiction counselor	2 years federal prison	May 13, 2026
Kenneth Iwamasa	Conspiracy to distribute ketamine causing death	Underway (recommended 41 months)	May 27, 2026

Erik Fleming, a licensed drug addiction counselor who sold 51 vials of ketamine to various customers including Perry, was sentenced to just 2 years in federal prison on May 13, 2026—a remarkably lighter sentence despite his role in the distribution network. This disparity highlights the prosecution’s focus on the more culpable parties: the physicians who violated their professional oath and the supplier who knowingly distributed deadly quantities of the drug.

“The emphasis on higher-profile cases and related prosecutions can play a crucial role in deterring illegal drug distribution networks that prey on vulnerable individuals struggling with addiction.”

— Legal analysis reported by CNN and legal experts examining the Matthew Perry prosecution, May 2026

Systemic Issues in Celebrity Healthcare and Addiction Treatment

The Matthew Perry case has exposed significant vulnerabilities in how medical professionals in Los Angeles and across the United States operate outside legitimate oversight. Both Dr. Salvador Plasencia and Dr. Mark Chavez operated facilities that sidestepped proper medical licensing and accountability protocols. Perry was never admitted to these clinics in conventional fashion—instead, doctors visited his home and administered ketamine without appropriate medical monitoring or consent procedures.

The case reveals a broader pattern: wealthy individuals struggling with addiction may be targeted by unscrupulous medical practitioners offering quick fixes with high-risk anesthetic drugs. Ketamine infusion therapy has legitimate clinical applications for treatment-resistant depression under proper medical supervision, but the practitioners in this case abandoned basic safety protocols. This industry gap persists because state licensing boards and federal regulators struggle to monitor physicians who operate outside traditional clinic settings and rely on cash payments rather than insurance documentation.

What This Sentencing Represents for Legal Accountability

Today’s sentencing of Kenneth Iwamasa marks completion of the first major federal prosecution targeting multiple actors in a celebrity drug death. U.S. Federal Court in Los Angeles has now demonstrated that personal assistants, medical professionals, and drug suppliers all face criminal liability for their roles in facilitating fatal overdoses. Judge Heather Garnett, who is presiding over the case, will determine whether to accept the prosecution’s recommendation of 41 months, grant a more lenient sentence in recognition of Iwamasa’s plea cooperation, or impose a harsher penalty reflecting the gravity of his liability.

The federal approach differs from typical overdose cases prosecuted at state level in California. Rather than charging Iwamasa solely with involuntary manslaughter, federal prosecutors built a case around conspiracy to distribute controlled substances resulting in death—a framework that allows them to reach the entire criminal enterprise. This strategy has produced longer sentences for the major actors (Sangha’s 15 years) and established precedent that healthcare workers and associates who enable drug distribution bear serious criminal responsibility.

Will This Case Change How Celebrities Access Medical Care?

Industry observers expect the Perry prosecution to reshape celebrity healthcare practices in Los Angeles and Beverly Hills. Medical professionals are more cautious about in-home drug administration. Celebrity rehab facilities now face increased scrutiny from state medical boards. Wealthy individuals seeking sedation or depression treatment will likely face stronger pressure to use established, accredited clinics rather than independent practitioners operating in private residences. The case underscores that money and fame do not insulate patients from the risks of unregulated medical care—in fact, these factors may increase vulnerability to predatory professionals.